Kala Pharmaceuticals Inc 0JQ2 Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
UK
LSE
Kala Pharmaceuticals Inc (0JQ2)
Kala Pharmaceuticals Inc (0JQ2) Financials

Kala Pharmaceuticals Inc (0JQ2)

15.40

0.00

( 0.00% )

Updated: 18:00:00

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0	6.07M	6.36M	17.05M	4.18M	230k
Operating Income	-32.67M	-39.88M	-64.72M	-88.22M	-96.23M	-130.25M	-81.71M	-39.66M
Pre Tax Income	-33.17M	-42.21M	-66.74M	-94.35M	-104.33M	-142.61M	-44.82M	-42.2M
Net Income	-33.17M	-42.21M	-66.74M	-94.35M	-104.33M	-142.61M	-44.82M	-42.2M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-5.39	-1.72	-1.971	-2.615	-1.771	-2.177	-26.258	-15.67
EBIT	-32.67M	-39.88M	-65.11M	-88.22M	-96.23M	-128.93M	-35.64M	-39.1M
EBITDA	-32.37M	-39.59M	-64.37M	-87.38M	-95.32M	-129.31M	-81.29M	-39.42M

Kala Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions